N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in rats-Reference-Cited by-同舟云学术

N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in rats

Published:2012-01 Issue:1 Volume:208 Page:82-91
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Yang Yi,Ciurlionis Rita,Kowalkowski Kenneth,Marsh Kennan C.,Bracken William M.,Blomme Eric A.G.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference45 articles.

1. Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems;Bachhav;Int. J. Pharm.,2006

2. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development;Blomme;Toxicol. Lett.,2009

3. Ein dimeres N-Vinylpyrrolidon

4. Breitenbach, J., Heger, R., Simon, D., 2003. Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone. United States Patent 6,599,931 (29.07.03).

5. Toxic response of the endocrine system;Capen,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver;Toxicologic Pathology;2023-10

2. Toxicogenomics: A Primer for Toxicologic Pathologists;Haschek and Rousseaux's Handbook of Toxicologic Pathology;2022

3. Effects of butylparaben exposure on thyroid peroxidase (TPO) and type 1 iodothyronine deiodinase (D1) in female Wistar rats;Toxicology;2020-10

4. Screening Strategies and Methods for Better Off-Target Liability Prediction and Identification of Small-Molecule Pharmaceuticals;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2018-09-10

5. Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective;Regulatory Toxicology and Pharmacology;2018-07